Regeneron Pharmaceuticals (NQ: REGN )
1,179.31
+3.98
(+0.34%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 16, 2024
Add to My Watchlist
All News about Regeneron Pharmaceuticals
![](https://ml.globenewswire.com/media/add5ebc7-88c9-49dc-8834-abbb07c622d1/small/regeneron-logo-jpg.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/earnings_image.jpeg?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2022/08/pharmaceutical1600.png)
![](/next-assets/images/schema-image-default.png)
Earnings Outlook For Regeneron Pharmaceuticals
February 01, 2024
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_1.jpeg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://www.chartmill.com/images/uploads/thumbnail_article_luc_kroeze_c1f44c837d.webp)
![](https://www.investors.com/wp-content/uploads/2020/12/Stock-sanofi-syringe-01-adobe.jpg)
![](https://ml.globenewswire.com/media/add5ebc7-88c9-49dc-8834-abbb07c622d1/small/regeneron-logo-jpg.jpg)
![](https://cdn.benzinga.com/files/images/story/2024/handshake-merger-shutter_0.jpeg?width=1200&height=800&fit=crop)
![](https://g.foolcdn.com/editorial/images/760117/doctor-with-patient-talking.jpg)
![](https://cdn.benzinga.com/files/images/story/2024/Microsoft-and-Apple.jpeg?width=1200&height=800&fit=crop)
![](https://g.foolcdn.com/editorial/images/762671/hands-behind-head-young-man.jpg)
![](https://cdn.benzinga.com/files/images/story/2024/SNY-REGN.png?width=1200&height=800&fit=crop)
Regeneron/Sanofi's Largest Selling Drug Dupixent Scores FDA Approval For Infants With Esophagus Inflammation
January 26, 2024
Via Benzinga
Exposures
Product Safety
![](https://ml.globenewswire.com/media/add5ebc7-88c9-49dc-8834-abbb07c622d1/small/regeneron-logo-jpg.jpg)
![](https://cdn.benzinga.com/files/images/story/2024/BIIB.png?width=1200&height=800&fit=crop)
![](https://ml.globenewswire.com/media/add5ebc7-88c9-49dc-8834-abbb07c622d1/small/regeneron-logo-jpg.jpg)
![](https://investorplace.com/wp-content/uploads/2019/07/blue-chip-money.jpg)
![](https://cdn.pixabay.com/photo/2018/07/15/10/44/dna-3539309_960_720.jpg)
![](https://cdn.benzinga.com/files/images/story/2024/ACRS.png?width=1200&height=800&fit=crop)
![](https://g.foolcdn.com/editorial/images/761396/counting-money-smiling-in-a-shop.jpg)
![](https://cdn.benzinga.com/files/images/story/2024/MarcChaikin_1.jpeg?width=1200&height=800&fit=crop)
![](https://www.investors.com/wp-content/uploads/2017/05/IRU33.jpg)
![](https://investorplace.com/wp-content/uploads/2022/10/biotechnology1600.png)
![](https://ml.globenewswire.com/media/add5ebc7-88c9-49dc-8834-abbb07c622d1/small/regeneron-logo-jpg.jpg)
![](https://www.investors.com/wp-content/uploads/2019/11/Stock-bounce-05-adobe.jpg)
![](https://www.investors.com/wp-content/uploads/2020/08/Stock-regeneron-01-shutt.jpg)
![](https://cdn.benzinga.com/files/images/story/2024/01/12/lab.microscope-3184432_1920.image_by_fernando_zhiminaicela_from_pixabay_.jpg?width=1200&height=800&fit=crop)
![](https://www.investors.com/wp-content/uploads/2017/10/stock-Merck-02-shutter.jpg)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.